Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial - Behr, J; Prasse, A; Kreuter, M (Lancet Respir Med, 2021)